The Lancet Global Health (Jul 2022)

The business case for vaccine and drug manufacturing in middle-income countries

  • Lenias Hwenda

Journal volume & issue
Vol. 10, no. 7
pp. e944 – e945

Abstract

Read online

No abstracts available.